FOI-03621

I am writing to confirm that I have now completed my search for the information you requested. ##Request You asked us: ‘We are interested in evaluating differences over time in GLP-1 receptor agonists prescribing in primary care settings in England. The data used for this piece of analytics will feed into British Heart Foundation's work on cardiovascular disease health inequalities. Time: Jan 2016 - most recent month Drug class: GLP-1 receptor agonists Drug types: liraglutide, semaglutide, tirzepatide Brand names: Saxenda, Wegovy, Mounjaro Geography: England, aggregated patient-level data by GP practice’ The NHS Business Services Authority (NHSBSA) received your request on 19 February 2026. We have handled your request under the Freedom of Information Act (FOIA) 2000. ##Our response Under Section 21 of the FOIA, we are not required to provide information in response to a request if it is already reasonably accessible to you. Please see the following link to view section 21 in full - https://www.legislation.gov.uk/ukpga/2000/36/section/21 The information you requested is available on our website: https://opendata.nhsbsa.net/dataset/english-prescribing-dataset-epd-with-snomed-code https://opendata.nhsbsa.net/dataset/english-prescribing-data-epd ##Advice and assistance The information can be located by opening each month and then by filtering it by the Chemical Substances required (liraglutide, semaglutide, tirzepatide). This will give the practice breakdown by items and quantity.